FundedIQ
Biotechnology

Amphix Bio: Funding, Investors & Team (Oct 2026)

Amphix Bio provides materials science, stem cell biology, biomolecular design, engineering, medical physics, and informatics. This has created translational opportunities for the development of novel therapies whose results in preclinical and clinical trials are promising.

www.amphixbio.com LinkedIn Chicago, United States 1-10 employees
Biotechnology Nanotechnology Product Research
Total raised
$13.5M
Rounds
2
Latest
Seed
Dec 2025

Amphix Bio has raised $13.5M across 2 funding rounds on record, the most recent a Seed of $12.5M announced in Dec 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Amphix Bio Company Profile and Key Stats

Total funding raised
$13.5M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$12.5M in Dec 2025
Employees
1-10
reported band
Headquarters
Chicago, United States

Latest funding round on record: Dec 2025.

Amphix Bio Funding Rounds

Date
Round
Amount
Seed
$12.5M
Undisclosed round
$1.0M

Amphix Bio raised $1.0M in an undisclosed round announced in Oct 2024.

1.2 years later, a Seed of $12.5M was announced in Dec 2025.

Amphix Bio Founders and Leadership Team

Name
Role
Contact
Nick Sather
Founder
Locked
Samuel Stupp
Founder
—

Contact details for the Amphix Bio team: 1 of 2 have an email address on file.

Start 14-day free trial →

Amphix Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

Amphix Bio's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Amphix Bio in Biotechnology and Chicago

Companies Similar to Amphix Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Amphix Bio Funding FAQs

What does Amphix Bio do?

Amphix Bio provides materials science, stem cell biology, biomolecular design, engineering, medical physics, and informatics. This has created translational opportunities for the development of novel therapies whose results in preclinical and clinical trials are promising.

How much funding has Amphix Bio raised?

Amphix Bio has raised $13.5M across 2 rounds on record. The most recent is a Seed of $12.5M announced in Dec 2025.

When did Amphix Bio last raise funding?

Amphix Bio's most recent funding round on record is a Seed of $12.5M, announced in Dec 2025.

Who founded Amphix Bio?

FundedIQ lists Nick Sather (Founder), Samuel Stupp (Founder) at Amphix Bio.

Where is Amphix Bio headquartered?

Amphix Bio is based in Chicago, Illinois, United States.

How many employees does Amphix Bio have?

Amphix Bio is in the 1-10 employee band.

How does Amphix Bio's funding compare to other Biotechnology startups?

Amphix Bio's latest round of $12.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Amphix Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Amphix Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.